title: In vitro induction of cytotoxic T lymphocytes against HTLV-I-infected T-cells from adult T-cell leukemia patients, asymptomatic HTLV-I carriers and seronegative healthy donors.
abstract: We investigated an in vitro method to produce cytotoxic T lymphocytes (CTLs) against HTLV-I-infected T-cells using peripheral blood mononuclear cells (PBMC) of adult T-cell leukemia (ATL) patients, asymptomatic HTLV-I carriers (AC) and seronegative healthy donors. The PBMC were restimulated repeatedly for 4 weeks with HLA-matched HTLV-I-infected T-cells which had been pretreated at 56 degrees C for 30 min to inactivate infectious HTLV-I. The culture medium included 10-100 units/ml of recombinant lymphokines (rIL-1, rIL-2, rIL-4, rIL-6 and rIL-7) and 10% fetal calf serum in RPMI-1640 medium. The cytotoxic activity was measured against HLA-matched HTLV-I-infected T-cell lines after CD4+ or CD8+ cells were positively panned from the cultured PBMC. The PBMC of ATL, AC and healthy donors were able to produce either CD4+ or CD8+ CTLs against HTLV-I-related antigens (env, gag, p21x, p27rex and p40tax) as well as the antigen(s) of as-yet unknown specificity expressed on HTLV-I-infected T-cells. All the CTLs recognized the specific antigens in the context of either class I or class II HLA types. These results indicated that ATL patients, AC and healthy donors were immunocompetent to generate CTLs against HTLV-I-infected T-cells and probably against HTLV-I-transformed T-cells.
authors.affiliation: Department of Dermatology, Faculty of Medicine, Kagoshima University.
authors.forename: Y
authors.initials: Y
authors.lastname: Katahira
authors.forename: S
authors.initials: S
authors.lastname: Yashiki
authors.forename: T
authors.initials: T
authors.lastname: Fujiyoshi
authors.forename: K
authors.initials: K
authors.lastname: Nomura
authors.forename: M
authors.initials: M
authors.lastname: Tara
authors.forename: M
authors.initials: M
authors.lastname: Mori
authors.forename: M
authors.initials: M
authors.lastname: Setoyama
authors.forename: T
authors.initials: T
authors.lastname: Kanzaki
authors.forename: H
authors.initials: H
authors.lastname: Shida
authors.forename: S
authors.initials: S
authors.lastname: Sonoda
mesh_terms: D000328:Adult; D000368:Aged; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D002353:Carrier State; D002460:Cell Line; D000939:Epitopes / Q000276:immunology; D015486:HTLV-I Antigens / Q000276:immunology; D006358:Hot Temperature; D015368:Human T-lymphotropic virus 1 / Q000276:immunology* / Q000502:physiology; D006801:Humans; D007564:Japan; D015458:Leukemia, T-Cell / Q000276:immunology*; D008875:Middle Aged; D013601:T-Lymphocytes / Q000276:immunology / Q000821:virology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
chemical_list: D000939:Epitopes; D015486:HTLV-I Antigens